BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15973594)

  • 1. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
    Carreira GC; Gemeinhardt O; Beyersdorff D; Schnorr J; Taupitz M; Lüdemann L
    Magn Reson Imaging; 2009 Apr; 27(3):360-9. PubMed ID: 18768279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K; Kaji Y; Fukabori Y; Yoshida K; Suganuma N; Sugimura K
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
    Franiel T; Lüdemann L; Taupitz M; Rost J; Asbach P; Beyersdorff D
    Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
    Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI. Value of two-compartment model].
    Kiessling F; Lichy M; Grobholz R; Farhan N; Heilmann M; Michel MS; Trojan L; Werner A; Rabe J; Delorme S; Kauczor HU; Schlemmer HP
    Radiologe; 2003 Jun; 43(6):474-80. PubMed ID: 12827262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.
    Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ
    Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI.
    Kershaw LE; Hutchinson CE; Buckley DL
    J Magn Reson Imaging; 2009 Mar; 29(3):641-8. PubMed ID: 19243046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.